Cosmetics Europe is preparing for challenges amid EU regulatory movement to clamp down on endocrine disruptors while also strategizing to defend CMR (carcinogenic, mutagenic or reprotoxic) substances within what could be a narrow timeframe for industry to build its case.
Cosmetics Europe Strategizing To Defend Ingredients Flagged As Endocrine Disruptors, CMRs
Clarification of requirements and a “demanding” timeline for industry’s defense of cosmetic ingredients identified as potentially carcinogenic, mutagenic or reprotoxic, and the Commission’s forthcoming list of potential endocrine disruptors in cosmetic products, are among challenges facing Cosmetics Europe in 2019 and beyond.
